Smoking Cessation Aids Market Global Analysis & Forecast 2028
戒烟辅助产品市场规模预计将从 2021 年的 234.1308 亿美元增至 2028 年的 640.323 亿美元。预计 2021 年至 2028 年期间,该市场的复合年增长率为 15.5%。
推动戒烟辅助市场增长的关键因素 是吸烟成瘾的增加、减少吸烟和烟草依赖的活动越来越多。然而,尼古丁替代疗法开发成本的上升可能会在一定程度上抑制未来几年市场的增长。
市场洞察
吸烟成瘾现象日益严重
尼古丁是烟草植物中发现的一种高度成瘾物质。吸烟已被证明是危险的,因为它会导致慢性健康问题、可预防的疾病、死亡和残疾。根据世界卫生组织 (WHO) 的数据,吸烟相关疾病每年在美国导致约 435,000 人死亡,相当于该国总死亡人数的五分之一。根据疾病控制和预防中心 (CDC) 的数据,2018 年,美国近 4000 万成年人吸烟。此外,约有 470 万初中和高中学生使用至少一种烟草产品,约有 1,600 名 18 岁以下的美国年轻人第一次吸烟。每年,近 50 万患者因吸烟引起的疾病而死亡。美国政府花费约 2250 亿美元用于治疗美国患有吸烟相关疾病的患者。因此,世界各国的吸烟率都很高。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
戒烟辅助市场:
复合年增长率(2021 - 2028 年)15.5%- 2021 年市场规模
234.1 亿美元 - 2028 年市场规模
640.3 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 辉瑞公司
- 葛兰素史克公司
- 雷迪博士实验室
- 强生服务公司
- 西普拉公司
- 百利高公司
- 博士伦保健公司
- 格兰马克
- 恩乔伊
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 尼古丁替代疗法
- 药物
- 电子香烟
- 其他的
- 医院药房
- 线上渠道
- 零售药店
- 其他最终用户
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
欧洲和亚洲各国的情况也类似。希腊、保加利亚、法国和克罗地亚是欧洲烟草消费量较高的国家。根据卫生指标与评估研究所的数据,吸烟在欧洲是一种非常普遍的瘾,因为超过 20% 的 15 岁以上成年人每天吸烟。此外,根据《世界人口评论》,吸烟率最高的是欧洲的东南亚和巴尔干半岛。《世界人口评论》还指出,在南亚和东南亚各国,男性吸烟率往往较高。例如,在印度尼西亚,2018 年男性吸烟率为 76.20%。因此,全球吸烟人口数量的增加推动了全球戒烟辅助市场的增长。
基于产品的洞察
根据产品,戒烟辅助市场分为尼古丁替代疗法、药物、电子香烟和其他。电子香烟被认为是烟草香烟的健康替代品,预计在预测期内将成为增长最快的细分市场。电子香烟是减少与烟草相关的健康状况的有效替代品,而尼古丁替代疗法对戒烟最有效。电子香烟是对烟草香烟的潜在威胁。此外,与普通香烟相比,电子香烟的危害较小,无烟且无被动吸烟的风险,即使在禁烟场所也可以使用,尼古丁含量不同,有各种口味可供选择,这些都是电子香烟市场的主要驱动因素。此外,电子香烟因其电子特性而越来越受欢迎,这是其需求不断增长的主要因素。
基于最终用户的洞察
根据最终用户,戒烟辅助市场分为医院药房、在线渠道、零售药店和其他最终用户。零售药店部分可能在 2021 年占据最大的市场份额,但在线渠道部分预计将在预测期内实现最高的复合年增长率。
辉瑞公司、葛兰素史克公司、雷迪博士实验室、强生服务公司、西普拉公司、百利高公司、博士伦、NJOY 和 Juul Labs 等主要参与者采用了多种有机和无机策略来提高其收入和市场地位。例如,2020 年 7 月,雷迪博士实验室在美国市场推出了 2 毫克和 4 毫克浓度的非处方尼古丁 Polacrilex 含片。此外,2020 年 11 月,百利高公司与美国癌症协会 (ACS) 合作完成了“戒烟更好”活动的第四年。
戒烟辅助市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 234.1亿美元 |
2028 年市场规模 | 640.3亿美元 |
全球复合年增长率(2021 - 2028) | 15.5% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
戒烟辅助产品市场 – 按产品分类
- 尼古丁替代疗法
- 药物
- 电子香烟
- 其他的
戒烟辅助产品市场 – 按最终用户划分
- 医院药房
- 线上渠道
- 零售药店
- 其他的
戒烟辅助产品市场 – 按地区划分
北美
- 我们
- 加拿大
- 墨西哥
欧洲
- 法国
- 德国
- 意大利
- 英国
- 西班牙
- 欧洲其他地区
亚太地区 (APAC)
- 中国
- 印度
- 日本
- 澳大利亚
- 韩国
- 亚太其他地区
中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲(SCAM)
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区
公司简介
- 辉瑞公司
- 葛兰素史克公司
- 雷迪博士实验室
- 强生服务公司
- 西普拉公司
- 百利高公司
- 博士伦保健公司
- 格兰马克
- 恩乔伊
- Juul 实验室
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Smoking Cessation Aids Market majorly consists of the players such as Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy's Laboratories, Johnson and Johnson Services, Inc., Cipla Inc., Perrigo Company plc, Bausch Health Companies Inc., Glenmark, NJOY, Juul Labs among others amongst others.
The US is the largest market for Smoking Cessation Aids at a global level. The market's growth is attributed to the Increasing implementation of various tobacco control programs, high expenditure in healthcare and wellness by the countries in the region and launch of new and innovative products by market players for smoking cessation are some of the factors likely to drive the Smoking Cessation Aids market in the region. According to CDC, in 2017, 14 of every 100 US adults aged 18 years or older (14.0%) currently smoke cigarettes. This hints at a high usage of de-addiction products. Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments working to educate and help people quit smoking that is engaged dedicatedly, to bring the number of smokers down.
Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to increasing awareness about the smoking cessation and nicotine de-addiction products, and a huge population base in the region. For instance, an international collaboration of researchers, led by those from Vanderbilt University in the United States, studied the trends in tobacco use in China, Japan, South Korea, Singapore, Taiwan, and India in Tobacco Smoking and Mortality in Asia, a pooled meta-analysis published by JAMA Network in March 2019. By 2030, it is anticipated that 8.3 million fatalities would be due to smoking. China, India, and Indonesia account for half of the world's male smokers, and Asia is the world's largest tobacco user and production.
The global Smoking Cessation Aids market based on product is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. In 2021, the electronic cigarettes segment held the largest share of the market, by product. The electronic cigarettes segment of Smoking Cessation Aids Market is also expected to witness fastest CAGR during 2021 to 2028.The increasing number of campaigns to reduce smoking and tobacco dependence are likely to increase the demand for the above-mentioned products. Therefore, it is expected that market is likely to propel during the forecast period.
The factors that are driving and restraining factors that will affect Smoking Cessation Aids Market in the coming years. Factors such as rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.
Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do not. Counseling, behavior therapy, medicines, and nicotine-containing products, such as nicotine patches, gum, lozenges, inhalers, and nasal sprays, may be used to help a person quit smoking.
The List of Companies - Smoking Cessation Aids Market
- Pfizer Inc.
- GlaxoSmithKline plc.
- Dr. Reddy's Laboratories
- Johnson and Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
- Juul Labs
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.